HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $262,000 | +9.2% | 9,910 | -19.2% | 0.00% | 0.0% |
Q4 2018 | $240,000 | +10.1% | 12,271 | +10.3% | 0.00% | 0.0% |
Q3 2018 | $218,000 | +18.5% | 11,122 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $184,000 | +16.5% | 11,122 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $158,000 | +29.5% | 11,122 | +33.3% | 0.00% | 0.0% |
Q4 2017 | $122,000 | +84.8% | 8,343 | +60.1% | 0.00% | 0.0% |
Q3 2017 | $66,000 | +6.5% | 5,210 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $62,000 | -6.1% | 5,210 | +15.9% | 0.00% | 0.0% |
Q1 2017 | $66,000 | -9.6% | 4,495 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $73,000 | -9.9% | 4,495 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $81,000 | +24.6% | 4,495 | +14.6% | 0.00% | 0.0% |
Q2 2016 | $65,000 | 0.0% | 3,922 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $65,000 | -23.5% | 3,922 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $85,000 | +157.6% | 3,922 | +136.8% | 0.00% | – |
Q3 2015 | $33,000 | +83.3% | 1,656 | +222.2% | 0.00% | – |
Q2 2015 | $18,000 | +100.0% | 514 | +53.4% | 0.00% | – |
Q1 2015 | $9,000 | – | 335 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |